Form D · Biotechnology

Powell Mansfield Inc.

San Diego, CA · CIK 0001724792

Offering snapshot reported Dec 24, 2019 · SEC filing

Reported sold
$1.13M
Offering amount: $1.18M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 27, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$567K$1.13MDec 12, 2017: $834,121.00Dec 12, 2017Dec 24, 2019: $1,134,086.00Dec 24, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$834,121 → $1,134,086
  • Reported investors10 → 12

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 24, 2019Amendment$1,134,086$299,965vs Dec 12, 201712SEC filing
Dec 12, 2017Initial$834,121No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-300476
Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.

Source: Form D, filed Dec 24, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Wayne Kay Director
Perry Mansfield Director, Executive
Christopher Studer Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3590 Camino Del Rio North, Suite 100
San Diego, CA, 92108